Telemedicine in the Time of The Pandemic

April 30, 2020

Get the latest recommendations on COVID-19 and learn about telemedicine for IBD management during the COVID-19 pandemic. Panelists will discuss how to be prepared for a TeleHealth visit, what to expect, what other virtual medicine options are available.

 

  • Moderators:

    Dr. Eric Benchimol (MD, PhD., FRCPC), Associate Professor and Gastroenterologist, Department of Pediatrics and School of Epidemology and Public Health at the University of Ottawa, Division of Gastroenterology​ at Children's Hospital of Eastern Ontario (CHEO) | Twitter: @ericbenchimol​

    Dr. Gilaad Kaplan (MD, MPH, FRCPC), Professor of Medicine, Gastroenterologist & Epidemiologist, Departments of Medicine and Community Health Sciences, University of Calgary. Chair, Scientific and Medical Advisory Council, Crohn’s and Colitis Canada | Twitter: @gilkaplan

    Panel Members: 

    Dr. Ted Xenodemetropoulos (MD, MSc, FRCPC), Associate Professor and Gastroenterologist, Department of Medicine, Division of Gastroenterology, McMaster University

    Dr. Vivian Huang (MD, MSc, FRCPC), Assistant Professor, Gastroenterologist, Division of Gastroenterology, Mount Sinai Hospital, University of Toronto, University of Alberta

    Dr. Geoffrey Nguyen (MD, PhD, FRCPC) Professor and Gastroenterologist, Department of Medicine, Institute for Health Policy Management and Evaluation, Division of Gastroenterology, University of Toronto, Mount Sinai Hospital


If you require further assistance, please click here.

 

Dr Benchimol and Dr Kaplan photos

Want to help boost our research initiatives?

Text CURE to 20222 to donate $25 to Crohn’s and Colitis Canada’s critical research projects.

READ MORE

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.